Pharmagreen Biotech Inc.
PHBI · OTC
9/30/2024 | 9/30/2023 | 9/30/2022 | 9/30/2021 | |
|---|---|---|---|---|
| Market Cap | $2,770 | $327 | $4,037 | $8,077 |
| - Cash | $0 | $1 | $8 | $25 |
| + Debt | $356 | $373 | $339 | $270 |
| Enterprise Value | $3,126 | $698 | $4,368 | $8,322 |
| Revenue | $3 | $3 | $0 | $0 |
| % Growth | 13.7% | – | – | – |
| Gross Profit | $2 | -$6 | $0 | -$435 |
| % Margin | 50.9% | -215% | – | – |
| EBITDA | -$971 | $26 | $194 | -$3,763 |
| % Margin | -28,480.5% | 879.4% | – | – |
| Net Income | -$1,004 | -$569 | -$875 | -$4,532 |
| % Margin | -29,442.8% | -18,979.3% | – | – |
| EPS Diluted | -0.002 | -0.001 | -0.002 | -0.015 |
| % Growth | -25% | 45.5% | 85.7% | – |
| Operating Cash Flow | -$28 | -$74 | -$427 | -$206 |
| Capital Expenditures | -$0 | $0 | $0 | $0 |
| Free Cash Flow | -$28 | -$74 | -$427 | -$206 |